Mednet Logo
HomePediatric Hematology/OncologyQuestion

What is the expected timeframe for the development of radiation myelitis and therapies that have helped with neurologic symptoms?

4
4 Answers
Mednet Member
Mednet Member
Radiation Oncology · University of Arizona

The incidence and the timeframe of the development of radiation myelopathy are influenced by total radiation dose, radiation dose per fraction, time between courses of radiation, and associated chemotherapy or immunotherapy. Older age, the presence of diabetes, and previous exposure to radiation are...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology · University of Pennsylvania Health System

Agree with Dr. @Dr. First Last and would add that timeline for the development of radiation myelopathy can be shorter with re-irradiation when compared to de novo treatment.

I have found this paper and a more recent publication helpful in designing my dose/fractionation when offering re-treatment ove...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology · University of New Mexico School of Medicine

I agree with Dr. @Dr. First Last, and can add that there is not much that appears to help with radiation myelopathy. There are a couple of options outside of steroid therapy.

Hyperbaric oxygen (HBO) appears to be of limited help in studies with rats, and case reports in humans have shown some benefit...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology · Maimonides Cancer Center
Drs. @Dr. First Last, @Dr. First Last, and @Dr. First Last, what is your perspective on employing bevacizumab as a salvage treatment for radiation-induced myelitis?

Register or Sign In to see full answer

What is the expected timeframe for the development of radiation myelitis and therapies that have helped with neurologic symptoms? | Mednet